Beijing, June 1 (Yang Lin) Recently, the Beijing Hubei cooperation team published a paper online in the international top academic journal Circulation (influence factor 23.054) under the title of "Prevalence, risk factors and outcomes of deep vein thrombosis in hospitalized patients with COVID-19".
The team is composed of Hubei Medical Team supported by Beijing, Zhang Liming Team of Respiratory and Critical Care Medicine Department of Beijing Chaoyang Hospital, Xie Mingxing Team of Ultrasonic Imaging Department of Union Hospital affiliated to Huazhong University of Science and Technology, and Hu Yu Team of Hematology Department.
This is the first time that the Beijing Hubei cooperation team has expounded the incidence, risk factors and impact on prognosis of deep vein thrombosis in patients with COVID-19 in a comprehensive, multi angle and multi-level manner in relevant global fields.
According to the team, the incidence of deep vein thrombosis in patients with ordinary, severe and critical COVID-19 was 13.5%, 43.9% and 66.2%, respectively. The main risk factors were CURB-65 scores 3-5 Padua prediction score is greater than or equal to 4 and D-dimer is greater than 1.0 μ g/ml. The sensitivity and specificity of establishing a joint prediction model based on the above three risk factors to predict deep vein thrombosis are 88.52% and 61.43% respectively. The mortality rate of patients with deep vein thrombosis is significantly higher than that of patients without deep vein thrombosis, Active preventive measures can reduce the incidence of deep vein thrombosis.
The Beijing Hubei cooperation team highlighted the results of this study to the global medical community, which helped reduce the death rate of COVID-19 in China and even the world, and contributed to China's strength.
